ArticleBMC chemistry2026
Simultaneous spectroscopic analysis of methocarbamol with its impurity guaifenesin: assessment of greenness, blueness and whiteness applying different sustainability tools.
Article in BMC chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work introduces an eco-friendly spectrophotometric approach for the simultaneous quantification of methocarbamol (MET) and its impurity product guaifenesin (GUF), based on measuring the second derivative amplitudes of each drug in presence of the other, using zero-crossing technique. The second derivative amplitudes were measured at 208.0 nm and at 207.5 nm for MET and GUF, respectively. The proposed method showed good linearity over the concentration ranges of 1.0-110.0 and 1.0-90.0 µg/mL for MET and GUF, respectively with corresponding correlation coefficient of 0.9997 and 0.9999. The detection and quantitation limits for MET were found to be 0.021 and 0.064 µg/mL, respectively, while GUF corresponding values were 0.013 and 0.041 µg/mL. The method was successfully applied for determining MET and GUF in its dosage forms with high selectivity. The developed method produced comparable results to those obtained by the published reference methods in terms of precision and accuracy. A comprehensive assessment was carried out to evaluate the suggested method's economic feasibility, practicality, and environmental sustainability compared to previously reported techniques. This comprehensive assessment leveraged several state-of-the-art tools, including the analytical Eco-scale, Green Analytical Procedure Index (GAPI), Analytical GREEnness (AGREE), Multi-Color Assessment, Analytical Green Star Area (AGSA) and Blueness Assessment Graphical Index tools. The suggested approach exhibited favorable quadrant profiles in GAPI assessment, along with higher AGREE, AGSA and Eco-scale scores, all of which confirmed their eco-friendliness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.